Aurobindo Pharma Limited (BOM:524804)
1,335.95
-6.15 (-0.46%)
At close: Apr 2, 2026
Aurobindo Pharma Employees
Aurobindo Pharma had 27,707 employees as of March 31, 2025. The number of employees increased by 1,692 or 6.50% compared to the previous year.
Employees
27,707
Change (1Y)
1,692
Growth (1Y)
6.50%
Revenue / Employee
11.98M INR
Profits / Employee
1.26M INR
Market Cap
774.62B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 27,707 | 1,692 | 6.50% |
| Mar 31, 2024 | 26,015 | 2,564 | 10.93% |
| Mar 31, 2023 | 23,451 | 8,020 | 51.97% |
| Mar 31, 2022 | 15,431 | -3,933 | -20.31% |
| Mar 31, 2021 | 19,364 | 895 | 4.85% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Dr. Reddy's Laboratories | 27,811 |
| Lupin | 24,006 |
| Torrent Pharmaceuticals | 17,059 |
| Jubilant Pharmova | 5,547 |
| J. B. Chemicals & Pharmaceuticals | 5,304 |
| Granules India | 4,066 |
| Caplin Point Laboratories | 3,966 |
| Abbott India | 3,659 |
Aurobindo Pharma News
- 1 day ago - Pharma sector stocks fall sharply today: Sun Pharma down 4.89%, Aurobindo Pharma falls 4.48%, Biocon drops 4.67% - Business Upturn
- 3 days ago - Aurobindo Pharma to complete 26% stake acquisition in Swarnaakshu Solar by June 2026 - Business Upturn
- 8 days ago - Aurobindo Pharma subsidiary CuraTeQ Biologics enters EU biosimilars agreement with STADA - Business Upturn
- 9 days ago - Top stocks to buy today: Stock recommendations for March 25, 2026 - check list - The Times of India
- 14 days ago - Aurobindo Pharma's subsidiary facility classified as 'Voluntary Action Indicated' by US FDA - Business Upturn
- 14 days ago - Pharma sector stocks surge today, March 20: Laurus Labs jumps 2.83%, Natco Pharma up 2.67%, Aurobindo Pharma gains 2.42% - Business Upturn
- 16 days ago - Aurobindo Pharma's Eugia Pharma unit classified as OAI by US FDA - Business Upturn
- 21 days ago - Aurobindo Pharma faces ₹77.61 crore GST demand and penalty - Business Upturn